| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vascular and Interventional Radiology |
1 From the Departments of Radiology (D.S.K.L., N.C.Y., S.S.R., P.L.), Pathology (C.L., K.M.), Medicine (M.J.T., R.G.A.), and Surgery (R.W.B.), UCLA School of Medicine, 10833 LeConte Ave, Los Angeles, CA 90095-1721. From the 2003 RSNA Annual Meeting. Received January 26, 2004; revision requested April 6; revision received June 9; accepted July 20. Address correspondence to D.S.K.L.
PURPOSE: To retrospectively evaluate the effectiveness of radiofrequency (RF) ablation of hepatocellular carcinoma (HCC) by using histologic examination of the explanted liver.
MATERIALS AND METHODS: The study was approved by the medical center Institutional Review Board, with waiver of informed consent. Forty-seven HCC nodules in 24 patients (18 men, six women; age range, 33–71 years; mean age, 56 years) were treated with single or double RF ablation sessions prior to liver transplantation. Histologic data from hematoxylin-eosin staining of explanted liver specimens were retrospectively reviewed to determine treatment success, which was defined as the absence of residual or recurrent viable carcinoma cells at treatment site. Tumor size and the presence of large (
3 mm) abutting vessels that were observed during imaging were tested as potential predictors of treatment success or failure (Fisher exact test). In patients who underwent postablation computed tomographic (CT) or magnetic resonance (MR) imaging within 3 months prior to transplantation (21 patients with 44 tumors), imaging results were analyzed for sensitivity and specificity of residual or recurrent tumor by using histologic data as the reference standard.
RESULTS: Thirty-five (74%) of 47 ablated tumors, including 29 (83%) of 35 tumors less than 3 cm, were found to be successfully treated on the basis of histologic findings after a mean interval of 7.5 months between RF ablation and transplantation. Nodules that were successfully treated had mean maximal diameter of 2.0 cm, and nodules that were unsuccessfully treated had mean maximal diameter of 3.1 cm (P = .014). Seven (47%) of 15 perivascular lesions were successfully treated whereas 28 (88%) of 32 nonperivascular lesions were successfully treated (P < .01). Imaging correlation showed 100% (33 of 33) specificity and 36% (four of 11) sensitivity of postablation CT and MR imaging for the depiction of residual or recurrent tumor.
CONCLUSION: Histologic evidence directly validates RF ablation as an effective treatment of small (<3 cm) HCC.
© RSNA, 2005
This article has been cited by other articles:
|
|
 |
|
  O. Seror, G. N'Kontchou, M. Ibraheem, Y. Ajavon, C. Barrucand, N. Ganne, E. Coderc, J. Claude Trinchet, M. Beaugrand, and N. Sellier Large (>=5.0-cm) HCCs: Multipolar RF Ablation with Three Internally Cooled Bipolar Electrodes--Initial Experience in 26 Patients Radiology, July 1, 2008; 248(1): 288 - 296. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M W LEE, Y J KIM, S W PARK, H J JEON, J G YI, W H CHOE, S Y KWON, and C H LEE Percutaneous radiofrequency ablation of liver dome hepatocellular carcinoma invisible on ultrasonography: a new targeting strategy Br. J. Radiol., May 1, 2008; 81(965): e130 - e134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Willatt, H. K. Hussain, S. Adusumilli, and J. A. Marrero MR Imaging of Hepatocellular Carcinoma in the Cirrhotic Liver: Challenges and Controversies Radiology, May 1, 2008; 247(2): 311 - 330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. X. Zhu and G. K. Abou-Alfa Expanding the Treatment Options for Hepatocellular Carcinoma: Combining Transarterial Chemoembolization With Radiofrequency Ablation JAMA, April 9, 2008; 299(14): 1716 - 1718. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Belghiti, B. I. Carr, P. D. Greig, R. Lencioni, and R. T. Poon Treatment before Liver Transplantation for HCC Ann. Surg. Oncol., April 1, 2008; 15(4): 993 - 1000. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. W.-T. Lam, K. K. Ng, K. S.-H. Chok, T.-T. Cheung, J. Yuen, H. Tung, W.-K. Tso, S.-T. Fan, and R. T. P. Poon Incomplete Ablation After Radiofrequency Ablation of Hepatocellular Carcinoma: Analysis of Risk Factors and Prognostic Factors Ann. Surg. Oncol., March 1, 2008; 15(3): 782 - 790. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. N. Wong, C.-J. Lin, C.-C. Lin, W.-T. Chen, I. H. Y. Cua, and S.-M. Lin Combined Percutaneous Radiofrequency Ablation and Ethanol Injection for Hepatocellular Carcinoma in High-Risk Locations Am. J. Roentgenol., March 1, 2008; 190(3): W187 - W195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hakime, A. Hines-Peralta, H. Peddi, M. B. Atkins, V. P. Sukhatme, S. Signoretti, M. Regan, and S. N. Goldberg Combination of Radiofrequency Ablation with Antiangiogenic Therapy for Tumor Ablation Efficacy: Study in Mice Radiology, August 1, 2007; 244(2): 464 - 470. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Schwartz Liver Transplantation: the Preferred Treatment for Early Hepatocellular Carcinoma in the Setting of Cirrhosis? Ann. Surg. Oncol., February 1, 2007; 14(2): 548 - 552. [Full Text] [PDF]
|
|
|
|
|
|
C. J. Simon, D. E. Dupuy, D. A. Iannitti, D. S. K. Lu, N. C. Yu, B. I. Aswad, R. W. Busuttil, and C. Lassman Intraoperative Triple Antenna Hepatic Microwave Ablation Am. J. Roentgenol., October 1, 2006; 187(4): W333 - W340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hines-Peralta, V. Sukhatme, M. Regan, S. Signoretti, Z.-j. Liu, and S. N. Goldberg Improved Tumor Destruction with Arsenic Trioxide and Radiofrequency Ablation in Three Animal Models Radiology, July 1, 2006; 240(1): 82 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. U. Hines-Peralta, N. Pirani, P. Clegg, N. Cronin, T. P. Ryan, Z. Liu, and S. N. Goldberg Microwave Ablation: Results with a 2.45-GHz Applicator in ex Vivo Bovine and in Vivo Porcine Liver Radiology, April 1, 2006; 239(1): 94 - 102. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |
